Global Neurological Biomarkers Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Neurological Biomarkers market is projected to reach US$ 15480 million by 2028 from an estimated US$ 7840.2 million in 2022, at a CAGR of 12.0% during 2023 and 2028.

Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.

North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.

In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neurological Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Neurological Biomarkers.

The Neurological Biomarkers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Neurological Biomarkers market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neurological Biomarkers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Thermo Fisher Scientific

Merck

Quest Diagnostics

Abbott

Roche

Illumina

Bio-Rad Laboratories

QIAGEN

Myriad RBM

Cisbio Bioassays

Athena Diagnostics

BGI

Wuxi APP

Aepodia

Proteome Sciences

Genewiz

Product Type Insights

Global markets are presented by Neurological Biomarkers type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Neurological Biomarkers are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Proteomics

Genomics

Imaging

Bioinformatics

Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Neurological Biomarkers market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Neurological Biomarkers market.

Diagnostics

Drug Discovery

Personalized Medicine

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Neurological Biomarkers market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurological Biomarkers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Neurological Biomarkers and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Neurological Biomarkers industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurological Biomarkers

1.1 Neurological Biomarkers Product Introduction

1.2 Market by Type

1.2.1 Global Neurological Biomarkers Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Proteomics

1.2.3 Genomics

1.2.4 Imaging

1.2.5 Bioinformatics

1.2.6 Others

1.3 Market by Application

1.3.1 Global Neurological Biomarkers Market Size Growth Rate by Application (2017 VS 2021 VS 2028)

1.3.2 Diagnostics

1.3.3 Drug Discovery

1.3.4 Personalized Medicine

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2.1 Global Neurological Biomarkers Market Size Estimates and Forecasts

2.1.1 Global Neurological Biomarkers Revenue 2017-2028

2.1.2 Global Neurological Biomarkers Sales 2017-2028

2.2 Neurological Biomarkers Market Size by Region: 2022 Versus 2028

2.3 Neurological Biomarkers Sales by Region (2017-2028)

2.3.1 Global Neurological Biomarkers Sales by Region: 2017-2022

2.3.2 Global Neurological Biomarkers Sales Forecast by Region (2023-2028)

2.3.3 Global Neurological Biomarkers Sales Market Share by Region (2017-2028)

2.4 Neurological Biomarkers Market Estimates and Projections by Region (2023-2028)

2.4.1 Global Neurological Biomarkers Revenue by Region: 2017-2022

2.4.2 Global Neurological Biomarkers Revenue Forecast by Region (2023-2028)

2.4.3 Global Neurological Biomarkers Revenue Market Share by Region (2017-2028)

3.1 Global Top Neurological Biomarkers Manufacturers by Sales

3.1.1 Global Neurological Biomarkers Sales by Manufacturer (2017-2022)

3.1.2 Global Neurological Biomarkers Sales Market Share by Manufacturer (2017-2022)

3.2 Global Top Neurological Biomarkers Manufacturers by Revenue

3.2.1 Global Neurological Biomarkers Revenue by Manufacturer (2017-2022)

3.2.2 Global Neurological Biomarkers Revenue Share by Manufacturer (2017-2022)

3.3 Global Neurological Biomarkers Price by Manufacturer (2017-2022)

3.4 Competitive Landscape

3.4.1 Key Neurological Biomarkers Manufacturers Covered: Ranking by Revenue

3.4.2 Global Neurological Biomarkers Market Concentration Ratio (CR5 and HHI) & (2017-2022)

3.4.3 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Neurological Biomarkers Manufacturing Base Distribution, Product Type

3.5.1 Neurological Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Neurological Biomarkers Product Type

3.5.3 Date of International Manufacturers Enter into Neurological Biomarkers Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.1 Thermo Fisher Scientific

4.1.1 Thermo Fisher Scientific Corporation Information

4.1.2 Thermo Fisher Scientific Description, Business Overview

4.1.3 Thermo Fisher Scientific Neurological Biomarkers Products Offered

4.1.4 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.1.5 Thermo Fisher Scientific Neurological Biomarkers Sales by Product in 2021

4.1.6 Thermo Fisher Scientific Neurological Biomarkers Sales by Application in 2021

4.1.7 Thermo Fisher Scientific Neurological Biomarkers Sales by Geographic Area in 2021

4.1.8 Thermo Fisher Scientific Recent Developments

4.2 Merck

4.2.1 Merck Corporation Information

4.2.2 Merck Description, Business Overview

4.2.3 Merck Neurological Biomarkers Products Offered

4.2.4 Merck Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.2.5 Merck Neurological Biomarkers Sales by Product in 2021

4.2.6 Merck Neurological Biomarkers Sales by Application in 2021

4.2.7 Merck Neurological Biomarkers Sales by Geographic Area in 2021

4.2.8 Merck Recent Developments

4.3 Quest Diagnostics

4.3.1 Quest Diagnostics Corporation Information

4.3.2 Quest Diagnostics Description, Business Overview

4.3.3 Quest Diagnostics Neurological Biomarkers Products Offered

4.3.4 Quest Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.3.5 Quest Diagnostics Neurological Biomarkers Sales by Product in 2021

4.3.6 Quest Diagnostics Neurological Biomarkers Sales by Application in 2021

4.3.7 Quest Diagnostics Neurological Biomarkers Sales by Geographic Area in 2021

4.3.8 Quest Diagnostics Recent Developments

4.4 Abbott

4.4.1 Abbott Corporation Information

4.4.2 Abbott Description, Business Overview

4.4.3 Abbott Neurological Biomarkers Products Offered

4.4.4 Abbott Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.4.5 Abbott Neurological Biomarkers Sales by Product in 2021

4.4.6 Abbott Neurological Biomarkers Sales by Application in 2021

4.4.7 Abbott Neurological Biomarkers Sales by Geographic Area in 2021

4.4.8 Abbott Recent Developments

4.5 Roche

4.5.1 Roche Corporation Information

4.5.2 Roche Description, Business Overview

4.5.3 Roche Neurological Biomarkers Products Offered

4.5.4 Roche Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.5.5 Roche Neurological Biomarkers Sales by Product in 2021

4.5.6 Roche Neurological Biomarkers Sales by Application in 2021

4.5.7 Roche Neurological Biomarkers Sales by Geographic Area in 2021

4.5.8 Roche Recent Developments

4.6 Illumina

4.6.1 Illumina Corporation Information

4.6.2 Illumina Description, Business Overview

4.6.3 Illumina Neurological Biomarkers Products Offered

4.6.4 Illumina Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.6.5 Illumina Neurological Biomarkers Sales by Product in 2021

4.6.6 Illumina Neurological Biomarkers Sales by Application in 2021

4.6.7 Illumina Neurological Biomarkers Sales by Geographic Area in 2021

4.6.8 Illumina Recent Development

4.7 Bio-Rad Laboratories

4.7.1 Bio-Rad Laboratories Corporation Information

4.7.2 Bio-Rad Laboratories Description, Business Overview

4.7.3 Bio-Rad Laboratories Neurological Biomarkers Products Offered

4.7.4 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.7.5 Bio-Rad Laboratories Neurological Biomarkers Sales by Product in 2021

4.7.6 Bio-Rad Laboratories Neurological Biomarkers Sales by Application in 2021

4.7.7 Bio-Rad Laboratories Neurological Biomarkers Sales by Geographic Area in 2021

4.7.8 Bio-Rad Laboratories Recent Development

4.8 QIAGEN

4.8.1 QIAGEN Corporation Information

4.8.2 QIAGEN Description, Business Overview

4.8.3 QIAGEN Neurological Biomarkers Products Offered

4.8.4 QIAGEN Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.8.5 QIAGEN Neurological Biomarkers Sales by Product in 2021

4.8.6 QIAGEN Neurological Biomarkers Sales by Application in 2021

4.8.7 QIAGEN Neurological Biomarkers Sales by Geographic Area in 2021

4.8.8 QIAGEN Recent Development

4.9 Myriad RBM

4.9.1 Myriad RBM Corporation Information

4.9.2 Myriad RBM Description, Business Overview

4.9.3 Myriad RBM Neurological Biomarkers Products Offered

4.9.4 Myriad RBM Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.9.5 Myriad RBM Neurological Biomarkers Sales by Product in 2021

4.9.6 Myriad RBM Neurological Biomarkers Sales by Application in 2021

4.9.7 Myriad RBM Neurological Biomarkers Sales by Geographic Area in 2021

4.9.8 Myriad RBM Recent Development

4.10 Cisbio Bioassays

4.10.1 Cisbio Bioassays Corporation Information

4.10.2 Cisbio Bioassays Description, Business Overview

4.10.3 Cisbio Bioassays Neurological Biomarkers Products Offered

4.10.4 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.10.5 Cisbio Bioassays Neurological Biomarkers Sales by Product in 2021

4.10.6 Cisbio Bioassays Neurological Biomarkers Sales by Application in 2021

4.10.7 Cisbio Bioassays Neurological Biomarkers Sales by Geographic Area in 2021

4.10.8 Cisbio Bioassays Recent Development

4.11 Athena Diagnostics

4.11.1 Athena Diagnostics Corporation Information

4.11.2 Athena Diagnostics Description, Business Overview

4.11.3 Athena Diagnostics Neurological Biomarkers Products Offered

4.11.4 Athena Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.11.5 Athena Diagnostics Neurological Biomarkers Sales by Product in 2021

4.11.6 Athena Diagnostics Neurological Biomarkers Sales by Application in 2021

4.11.7 Athena Diagnostics Neurological Biomarkers Sales by Geographic Area in 2021

4.11.8 Athena Diagnostics Recent Development

4.12 BGI

4.12.1 BGI Corporation Information

4.12.2 BGI Description, Business Overview

4.12.3 BGI Neurological Biomarkers Products Offered

4.12.4 BGI Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.12.5 BGI Neurological Biomarkers Sales by Product in 2021

4.12.6 BGI Neurological Biomarkers Sales by Application in 2021

4.12.7 BGI Neurological Biomarkers Sales by Geographic Area in 2021

4.12.8 BGI Recent Development

4.13 Wuxi APP

4.13.1 Wuxi APP Corporation Information

4.13.2 Wuxi APP Description, Business Overview

4.13.3 Wuxi APP Neurological Biomarkers Products Offered

4.13.4 Wuxi APP Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.13.5 Wuxi APP Neurological Biomarkers Sales by Product in 2021

4.13.6 Wuxi APP Neurological Biomarkers Sales by Application in 2021

4.13.7 Wuxi APP Neurological Biomarkers Sales by Geographic Area in 2021

4.13.8 Wuxi APP Recent Development

4.14 Aepodia

4.14.1 Aepodia Corporation Information

4.14.2 Aepodia Description, Business Overview

4.14.3 Aepodia Neurological Biomarkers Products Offered

4.14.4 Aepodia Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.14.5 Aepodia Neurological Biomarkers Sales by Product in 2021

4.14.6 Aepodia Neurological Biomarkers Sales by Application in 2021

4.14.7 Aepodia Neurological Biomarkers Sales by Geographic Area in 2021

4.14.8 Aepodia Recent Development

4.15 Proteome Sciences

4.15.1 Proteome Sciences Corporation Information

4.15.2 Proteome Sciences Description, Business Overview

4.15.3 Proteome Sciences Neurological Biomarkers Products Offered

4.15.4 Proteome Sciences Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.15.5 Proteome Sciences Neurological Biomarkers Sales by Product in 2021

4.15.6 Proteome Sciences Neurological Biomarkers Sales by Application in 2021

4.15.7 Proteome Sciences Neurological Biomarkers Sales by Geographic Area in 2021

4.15.8 Proteome Sciences Recent Development

4.16 Genewiz

4.16.1 Genewiz Corporation Information

4.16.2 Genewiz Description, Business Overview

4.16.3 Genewiz Neurological Biomarkers Products Offered

4.16.4 Genewiz Neurological Biomarkers Sales, Revenue and Gross Margin (2017-2022)

4.16.5 Genewiz Neurological Biomarkers Sales by Product in 2021

4.16.6 Genewiz Neurological Biomarkers Sales by Application in 2021

4.16.7 Genewiz Neurological Biomarkers Sales by Geographic Area in 2021

4.16.8 Genewiz Recent Development

5.1 Global Neurological Biomarkers Sales by Type (2017-2028)

5.1.1 Global Neurological Biomarkers Sales by Type (2017-2022)

5.1.2 Global Neurological Biomarkers Sales Forecast by Type (2023-2028)

5.1.3 Global Neurological Biomarkers Sales Market Share by Type (2017-2028)

5.2 Global Neurological Biomarkers Revenue Forecast by Type (2017-2028)

5.2.1 Global Neurological Biomarkers Revenue by Type (2017-2022)

5.2.2 Global Neurological Biomarkers Revenue Forecast by Type (2023-2028)

5.2.3 Global Neurological Biomarkers Revenue Market Share by Type (2017-2028)

5.3 Neurological Biomarkers Average Selling Price (ASP) by Type (2017-2028)

6.1 Global Neurological Biomarkers Sales by Application (2017-2028)

6.1.1 Global Neurological Biomarkers Sales by Application (2017-2022)

6.1.2 Global Neurological Biomarkers Sales Forecast by Application (2023-2028)

6.1.3 Global Neurological Biomarkers Sales Market Share by Application (2017-2028)

6.2 Global Neurological Biomarkers Revenue Forecast by Application (2017-2028)

6.2.1 Global Neurological Biomarkers Revenue by Application (2017-2022)

6.2.2 Global Neurological Biomarkers Revenue Forecast by Application (2023-2028)

6.2.3 Global Neurological Biomarkers Revenue Market Share by Application (2017-2028)

6.3 Neurological Biomarkers Average Selling Price (ASP) by Application (2017-2028)

7.1 North America Neurological Biomarkers Market Size YoY Growth 2017-2028

7.2 North America Neurological Biomarkers Market Facts & Figures by Country

7.2.1 North America Neurological Biomarkers Sales by Country (2017-2028)

7.2.2 North America Neurological Biomarkers Revenue by Country (2017-2028)

7.3 North America Neurological Biomarkers Sales by Type

7.4 North America Neurological Biomarkers Sales by Application

8.1 Asia-Pacific Neurological Biomarkers Market Size YoY Growth 2017-2028

8.2 Asia-Pacific Neurological Biomarkers Market Facts & Figures by Region

8.2.1 Asia-Pacific Neurological Biomarkers Sales by Region (2017-2028)

8.2.2 Asia-Pacific Neurological Biomarkers Revenue by Region (2017-2028)

8.3 Asia-Pacific Neurological Biomarkers Sales by Type

8.4 Asia-Pacific Neurological Biomarkers Sales by Application

9.1 Europe Neurological Biomarkers Market Size YoY Growth 2017-2028

9.2 Europe Neurological Biomarkers Market Facts & Figures by Country

9.2.1 Europe Neurological Biomarkers Sales by Country (2017-2028)

9.2.2 Europe Neurological Biomarkers Revenue by Country (2017-2028)

9.3 Europe Neurological Biomarkers Sales by Type

9.4 Europe Neurological Biomarkers Sales by Application

10.1 Latin America Neurological Biomarkers Market Size YoY Growth 2017-2028

10.2 Latin America Neurological Biomarkers Market Facts & Figures by Country

10.2.1 Latin America Neurological Biomarkers Sales by Country (2017-2028)

10.2.2 Latin America Neurological Biomarkers Revenue by Country (2017-2028)

10.3 Latin America Neurological Biomarkers Sales by Type

10.4 Latin America Neurological Biomarkers Sales by Application

11.1 Middle East and Africa Neurological Biomarkers Market Size YoY Growth 2017-2028

11.2 Middle East and Africa Neurological Biomarkers Market Facts & Figures by Country

11.2.1 Middle East and Africa Neurological Biomarkers Sales by Country (2017-2028)

11.2.2 Middle East and Africa Neurological Biomarkers Revenue by Country (2017-2028)

11.3 Middle East and Africa Neurological Biomarkers Sales by Type

11.4 Middle East and Africa Neurological Biomarkers Sales by Application

12.1 Neurological Biomarkers Supply Chain Analysis

12.2 Neurological Biomarkers Key Raw Materials and Upstream Suppliers

12.3 Neurological Biomarkers Clients Analysis

12.4 Neurological Biomarkers Sales Channel and Sales Model Analysis

12.4.1 Neurological Biomarkers Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Neurological Biomarkers Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Neurological Biomarkers Distributors

13.1 Neurological Biomarkers Industry Trends

13.2 Neurological Biomarkers Market Drivers

13.3 Neurological Biomarkers Market Challenges

13.4 Neurological Biomarkers Market Restraints

13.5 Porter’s Five Forces Analysis

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global Neurological Biomarkers Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Major Manufacturers of Proteomics

    Table 3. Major Manufacturers of Genomics

    Table 4. Major Manufacturers of Imaging

    Table 5. Major Manufacturers of Bioinformatics

    Table 6. Major Manufacturers of Others

    Table 7. Global Neurological Biomarkers Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 8. Global Neurological Biomarkers Market Size by Region (US$ Million): 2021 VS 2022 VS 2028

    Table 9. Global Neurological Biomarkers Sales by Region (2017-2022) & (K Units)

    Table 10. Global Neurological Biomarkers Sales Forecast by Region (2023-2028) & (K Units)

    Table 11. Global Neurological Biomarkers Revenue by Region (2017-2022) & (US$ Million)

    Table 12. Global Neurological Biomarkers Revenue Forecast by Region (2023-2028) & (US$ Million)

    Table 13. Global Neurological Biomarkers Sales by Manufacturer (2017-2022) & (K Units)

    Table 14. Global Neurological Biomarkers Sales Share by Manufacturer (2017-2022)

    Table 15. Neurological Biomarkers Revenue by Manufacturer (2017-2022) & (US$ Million)

    Table 16. Neurological Biomarkers Revenue Share by Manufacturer (2017-2022)

    Table 17. Key Manufacturers Neurological Biomarkers Price (2017-2022) & (USD/Unit)

    Table 18. Ranking of Global Top Neurological Biomarkers Manufacturers by Revenue (US$ Million) in 2021

    Table 19. Global Neurological Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)

    Table 20. Global Neurological Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurological Biomarkers as of 2021)

    Table 21. Neurological Biomarkers Manufacturers Manufacturing Base Distribution and Headquarters

    Table 22. Manufacturers Neurological Biomarkers Product Type

    Table 23. Date of International Manufacturers Enter into Neurological Biomarkers Market

    Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 25. Thermo Fisher Scientific Corporation Information

    Table 26. Thermo Fisher Scientific Description and Business Overview

    Table 27. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 28. Thermo Fisher Scientific Neurological Biomarkers Product

    Table 29. Thermo Fisher Scientific Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 30. Thermo Fisher Scientific Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 31. Thermo Fisher Scientific Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 32. Thermo Fisher Scientific Recent Development

    Table 33. Merck Corporation Information

    Table 34. Merck Description and Business Overview

    Table 35. Merck Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 36. Merck Neurological Biomarkers Product

    Table 37. Merck Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 38. Merck Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 39. Merck Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 40. Merck Recent Development

    Table 41. Quest Diagnostics Corporation Information

    Table 42. Quest Diagnostics Description and Business Overview

    Table 43. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 44. Quest Diagnostics Neurological Biomarkers Product

    Table 45. Quest Diagnostics Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 46. Quest Diagnostics Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 47. Quest Diagnostics Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 48. Quest Diagnostics Recent Development

    Table 49. Abbott Corporation Information

    Table 50. Abbott Description and Business Overview

    Table 51. Abbott Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 52. Abbott Neurological Biomarkers Product

    Table 53. Abbott Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 54. Abbott Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 55. Abbott Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 56. Abbott Recent Development

    Table 57. Roche Corporation Information

    Table 58. Roche Description and Business Overview

    Table 59. Roche Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 60. Roche Neurological Biomarkers Product

    Table 61. Roche Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 62. Roche Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 63. Roche Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 64. Roche Recent Development

    Table 65. Illumina Corporation Information

    Table 66. Illumina Description and Business Overview

    Table 67. Illumina Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 68. Illumina Neurological Biomarkers Product

    Table 69. Illumina Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 70. Illumina Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 71. Illumina Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 72. Bio-Rad Laboratories Corporation Information

    Table 73. Bio-Rad Laboratories Description and Business Overview

    Table 74. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 75. Bio-Rad Laboratories Neurological Biomarkers Product

    Table 76. Bio-Rad Laboratories Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 77. Bio-Rad Laboratories Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 78. Bio-Rad Laboratories Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 79. QIAGEN Corporation Information

    Table 80. QIAGEN Description and Business Overview

    Table 81. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 82. QIAGEN Neurological Biomarkers Product

    Table 83. QIAGEN Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 84. QIAGEN Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 85. QIAGEN Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 86. Myriad RBM Corporation Information

    Table 87. Myriad RBM Description and Business Overview

    Table 88. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 89. Myriad RBM Neurological Biomarkers Product

    Table 90. Myriad RBM Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 91. Myriad RBM Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 92. Myriad RBM Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 93. Cisbio Bioassays Corporation Information

    Table 94. Cisbio Bioassays Description and Business Overview

    Table 95. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 96. Cisbio Bioassays Neurological Biomarkers Product

    Table 97. Cisbio Bioassays Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 98. Cisbio Bioassays Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 99. Cisbio Bioassays Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 100. Athena Diagnostics Corporation Information

    Table 101. Athena Diagnostics Description and Business Overview

    Table 102. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 103. Athena Diagnostics Neurological Biomarkers Product

    Table 104. Athena Diagnostics Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 105. Athena Diagnostics Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 106. Athena Diagnostics Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 107. BGI Corporation Information

    Table 108. BGI Description and Business Overview

    Table 109. BGI Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 110. BGI Neurological Biomarkers Product

    Table 111. BGI Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 112. BGI Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 113. BGI Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 114. Wuxi APP Corporation Information

    Table 115. Wuxi APP Description and Business Overview

    Table 116. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 117. Wuxi APP Neurological Biomarkers Product

    Table 118. Wuxi APP Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 119. Wuxi APP Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 120. Wuxi APP Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 121. Aepodia Corporation Information

    Table 122. Aepodia Description and Business Overview

    Table 123. Aepodia Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 124. Aepodia Neurological Biomarkers Product

    Table 125. Aepodia Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 126. Aepodia Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 127. Aepodia Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 128. Proteome Sciences Corporation Information

    Table 129. Proteome Sciences Description and Business Overview

    Table 130. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 131. Proteome Sciences Neurological Biomarkers Product

    Table 132. Proteome Sciences Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 133. Proteome Sciences Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 134. Proteome Sciences Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 135. Genewiz Corporation Information

    Table 136. Genewiz Description and Business Overview

    Table 137. Genewiz Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 138. Genewiz Neurological Biomarkers Product

    Table 139. Genewiz Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Product in 2021

    Table 140. Genewiz Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Application in 2021

    Table 141. Genewiz Neurological Biomarkers Sales Proportion of Neurological Biomarkers by Geographic Area in 2021

    Table 142. Global Neurological Biomarkers Sales by Type (2017-2022) & (K Units)

    Table 143. Global Neurological Biomarkers Sales Forecast by Type (2023-2028) & (K Units)

    Table 144. Global Neurological Biomarkers Revenue by Type (2017-2022) & (US$ Million)

    Table 145. Global Neurological Biomarkers Revenue Forecast by Type (2023-2028) & (US$ Million)

    Table 146. Global Neurological Biomarkers Sales by Application (2017-2022) & (K Units)

    Table 147. Global Neurological Biomarkers Sales Forecast by Application (2023-2028) & (K Units)

    Table 148. Global Neurological Biomarkers Revenue by Application (2017-2022) & (US$ Million)

    Table 149. Global Neurological Biomarkers Revenue Forecast by Application (2023-2028) & (US$ Million)

    Table 150. North America Neurological Biomarkers Sales by Country (2017-2022) & (K Units)

    Table 151. North America Neurological Biomarkers Sales by Country (2023-2028) & (K Units)

    Table 152. North America Neurological Biomarkers Revenue by Country (2017-2022) & (US$ Million)

    Table 153. North America Neurological Biomarkers Revenue by Country (2023-2028) & (US$ Million)

    Table 154. North America Neurological Biomarkers Sales by Type (2017-2022) & (K Units)

    Table 155. North America Neurological Biomarkers Sales by Application (2017-2022) & (K Units)

    Table 156. Asia-Pacific Neurological Biomarkers Sales by Region (2017-2022) & (K Units)

    Table 157. Asia-Pacific Neurological Biomarkers Sales by Region (2023-2028) & (K Units)

    Table 158. Asia-Pacific Neurological Biomarkers Revenue by Region (2017-2028) & (US$ Million)

    Table 159. Asia-Pacific Neurological Biomarkers Revenue by Region (2023-2028) & (US$ Million)

    Table 160. Asia-Pacific Neurological Biomarkers Sales by Type (2017-2022) & (K Units)

    Table 161. Asia-Pacific Neurological Biomarkers Sales by Application (2017-2022) & (K Units)

    Table 162. Europe Neurological Biomarkers Sales by Country (2017-2022) & (K Units)

    Table 163. Europe Neurological Biomarkers Sales by Country (2023-2028) & (K Units)

    Table 164. Europe Neurological Biomarkers Revenue by Country (2017-2022) & (US$ Million)

    Table 165. Europe Neurological Biomarkers Revenue by Country (2023-2028) & (US$ Million)

    Table 166. Europe Neurological Biomarkers Sales by Type (2017-2022) & (K Units)

    Table 167. Europe Neurological Biomarkers Sales by Application (2017-2022) & (K Units)

    Table 168. Latin America Neurological Biomarkers Sales by Country (2017-2022) & (K Units)

    Table 169. Latin America Neurological Biomarkers Sales by Country (2023-2028) & (K Units)

    Table 170. Latin America Neurological Biomarkers Revenue by Country (2017-2022) & (US$ Million)

    Table 171. Latin America Neurological Biomarkers Revenue by Country (2023-2028) & (US$ Million)

    Table 172. Latin America Neurological Biomarkers Sales by Type (2017-2022) & (K Units)

    Table 173. Latin America Neurological Biomarkers Sales by Application (2017-2022) & (K Units)

    Table 174. Middle East and Africa Neurological Biomarkers Sales by Country (2017-2022) & (K Units)

    Table 175. Middle East and Africa Neurological Biomarkers Sales by Country (2023-2028) & (K Units)

    Table 176. Middle East and Africa Neurological Biomarkers Revenue by Country (2017-2022) & (US$ Million)

    Table 177. Middle East and Africa Neurological Biomarkers Revenue by Country (2023-2028) & (US$ Million)

    Table 178. Middle East and Africa Neurological Biomarkers Sales by Type (2017-2022) & (K Units)

    Table 179. Middle East and Africa Neurological Biomarkers Sales by Application (2017-2022) & (K Units)

    Table 180. Neurological Biomarkers Key Raw Materials, Industry Status and Trend

    Table 181. Neurological Biomarkers Key Raw Materials and Upstream Suppliers

    Table 182. Neurological Biomarkers Clients Status and Trend

    Table 183. Neurological Biomarkers Typical Clients

    Table 184. Neurological Biomarkers Distributors

    Table 185. Neurological Biomarkers Market Trends

    Table 186. Neurological Biomarkers Market Drivers

    Table 187. Neurological Biomarkers Market Challenges

    Table 188. Neurological Biomarkers Market Restraints

    Table 189. Research Programs/Design for This Report

    Table 190. Key Data Information from Secondary Sources

    Table 191. Key Data Information from Primary Sources

List of Figures

    Figure 1. Neurological Biomarkers Product Picture

    Figure 2. Global Neurological Biomarkers Sales Market Share by Type in 2021 & 2028

    Figure 3. Proteomics Product Picture

    Figure 4. Genomics Product Picture

    Figure 5. Imaging Product Picture

    Figure 6. Bioinformatics Product Picture

    Figure 7. Others Product Picture

    Figure 8. Global Neurological Biomarkers Sales Market Share by Application in 2021 & 2028

    Figure 9. Diagnostics Examples

    Figure 10. Drug Discovery Examples

    Figure 11. Personalized Medicine Examples

    Figure 12. Others Examples

    Figure 13. Neurological Biomarkers Report Years Considered

    Figure 14. Global Neurological Biomarkers Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 15. Global Neurological Biomarkers Market Size 2017-2028 (US$ Million)

    Figure 16. Global Neurological Biomarkers Sales 2017-2028 (K Units)

    Figure 17. Global Neurological Biomarkers Market Size Market Share by Region: 2022 Versus 2028

    Figure 18. Global Neurological Biomarkers Sales Market Share Forecast by Region (2017-2028)

    Figure 19. Global Neurological Biomarkers Revenue Market Share by Region (2017-2028)

    Figure 20. Global Neurological Biomarkers Sales Share by Manufacturer in 2021

    Figure 21. Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

    Figure 22. Global Neurological Biomarkers Sales Market Share Forecast by Type (2017-2028)

    Figure 23. Global Neurological Biomarkers Revenue Market Share Forecast by Type (2017-2028)

    Figure 24. Neurological Biomarkers Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)

    Figure 25. Global Neurological Biomarkers Sales Market Share Forecast by Application (2017-2028)

    Figure 26. Global Neurological Biomarkers Revenue Market Share Forecast by Application (2017-2028)

    Figure 27. Neurological Biomarkers Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)

    Figure 28. North America Neurological Biomarkers Revenue 2017-2028 (US$ Million)

    Figure 29. North America Neurological Biomarkers Sales Market Share by Type (2017-2022)

    Figure 30. North America Neurological Biomarkers Sales Market Share by Application (2017-2022)

    Figure 31. Asia-Pacific Neurological Biomarkers Revenue 2017-2028 (US$ Million)

    Figure 32. Asia-Pacific Neurological Biomarkers Sales Market Share by Region (2017-2028)

    Figure 33. Asia-Pacific Neurological Biomarkers Revenue Market Share by Region (2017-2028)

    Figure 34. Asia-Pacific Neurological Biomarkers Sales Market Share by Type (2017-2022)

    Figure 35. Asia-Pacific Neurological Biomarkers Sales Market Share by Application (2017-2022)

    Figure 36. Europe Neurological Biomarkers Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 37. Europe Neurological Biomarkers Sales Market Share by Country (2017-2028)

    Figure 38. Europe Neurological Biomarkers Revenue Market Share by Country (2017-2028)

    Figure 39. Europe Neurological Biomarkers Sales Market Share by Type (2017-2022)

    Figure 40. Europe Neurological Biomarkers Sales Market Share by Application (2017-2022)

    Figure 41. Latin America Neurological Biomarkers Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 42. Latin America Neurological Biomarkers Sales Market Share by Country (2017-2028)

    Figure 43. Latin America Neurological Biomarkers Revenue Market Share by Country (2017-2022)

    Figure 44. Latin America Neurological Biomarkers Sales Market Share by Type (2017-2022)

    Figure 45. Latin America Neurological Biomarkers Sales Market Share by Application (2017-2022)

    Figure 46. Middle East and Africa Neurological Biomarkers Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 47. Middle East and Africa Neurological Biomarkers Sales Market Share by Country (2017-2028)

    Figure 48. Middle East and Africa Neurological Biomarkers Revenue Market Share by Country (2017-2028)

    Figure 49. Middle East and Africa Neurological Biomarkers Sales Market Share by Type (2017-2022)

    Figure 50. Middle East and Africa Neurological Biomarkers Sales Market Share by Application (2017-2022)

    Figure 51. Neurological Biomarkers Supply Chain (Upstream and Downstream Market)

    Figure 52. Global Production Market Share of Neurological Biomarkers Raw Materials by Region in 2021

    Figure 53. Neurological Biomarkers Distribution Channels

    Figure 54. Global Neurological Biomarkers Percentage 2017-2028: Indirect Sales VS Direct Sales

    Figure 55. Global Neurological Biomarkers Percentage 2017-2028: Online Sales VS Offline Sales

    Figure 56. Bottom-up and Top-down Approaches for This Report

    Figure 57. Data Triangulation